Horizon Entered into a Multi-Year Scientific Collaboration with Johns Hopkins University School of Medicine to Advance Research in Autoimmunity and Inflammation
Shots:
- Horizon & Johns Hopkins University School of Medicine collaborated to identify novel metabolic pathways & new disease targets along with developing therapies for serious autoimmune and inflammatory conditions
- The team will expedite translational and research efforts to address the unique needs of different patient populations by combining Johns Hopkins’ capabilities and Horizon’s expertise in autoimmunity in pre-clinical research
- The collaboration initially focused on the newly emerging field of immunometabolism, the study of metabolic processes in the body which on dysregulated can cause autoimmunity and inflammation
Ref: Horizon | Image: Horizon
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
